Your challenge - Patient Adherence
70% of patients who begin a therapy discontinue it within one year.
Put another way, increased adherence of a mere 5% for a product with approximately $1bill in sales would translate to an additional $30-$40m in annual revenue for you.
No longer can companies ignore the hidden value available by increasing patient adherence, but it's important to realize that patient adherence programs are not a 'one size fits all' approach.
The winning approach allows companies to:
- Understand how adherence issues influence physician prescribing patterns.
- Quantify the impact of adherence on the brand.
- Identify rational and emotional aspects that assist or hinder patient adherence.
- Identify adherence programs that will provide the greatest effect on a brand's market share.
- Quantify the potential prescribing impact of such adherence programs alone or in combination.
- Clarify the optimal mix of adherence activities to maximize growth.
Our solution
We work with clients and uncover the underlying reasons for patient non-adherence, and its financial impact on the brand's value and market share. Then we will design appropriate programs for each brand. Only then can the ROI of such intervention be accurately assessed and the optimal solutions be implemented.
The Eularis 94.8 Analytics System simplifies the process, encourages buy-in across the company, and eliminates your anxiety in dealing with this perplexing issue.
Ensuring Profitable Patient Adherence Programs
This report, written by Dr Andree Bates of Eularis, examines adherence among today.
Download report
Read our report
Contact us today to find out how we can help with Patient Adherence.